News on Avecia Biologics Limited from BioPortfolio.com http://www.BioPortfolio.com Consolidated Avecia Biologics Limited news from BioPortfolio.com Wed, 10 Feb 2010 16:22:30 GMT en Boosting efficiency and safety by minimising aggregationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990662&HITNO=0&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990662&THISHREF=http://c.moreover.com/click/here.pl%3fz2513400427%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990662&HITNO=0&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990662&THISHREF=http://c.moreover.com/click/here.pl%3fz2513400427%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Watson Completes Acquisition of Eden Biodesignhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988794&HITNO=1&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988794&THISHREF=http://c.moreover.com/click/here.pl%3fz2511526260%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988794&HITNO=1&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988794&THISHREF=http://c.moreover.com/click/here.pl%3fz2511526260%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Merck & Co., Inc. To Acquire Avecia Biologicshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885100&HITNO=2&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885100&THISHREF=http://c.moreover.com/click/here.pl%3fz2457287529%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885100&HITNO=2&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885100&THISHREF=http://c.moreover.com/click/here.pl%3fz2457287529%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery Online: Merck & Co., Inc. To Acquire Avecia Biologicshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885088&HITNO=3&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885088&THISHREF=http://c.moreover.com/click/here.pl%3fz2457286199%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885088&HITNO=3&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885088&THISHREF=http://c.moreover.com/click/here.pl%3fz2457286199%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioresearch Online: Avecia Deal Marks Greater Biologics Commitment For Merck & Cohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3882163&HITNO=4&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3882163&THISHREF=http://c.moreover.com/click/here.pl%3fz2454364219%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3882163&HITNO=4&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3882163&THISHREF=http://c.moreover.com/click/here.pl%3fz2454364219%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCorporate Financing Week: World Class Leaders From NCI/OBBR, NIH/OBA, Schering Plough, Merck,deCode Genetics, Biobusiness Consulting, Nahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858579&HITNO=5&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858579&THISHREF=http://c.moreover.com/click/here.pl%3fz2443353371%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858579&HITNO=5&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858579&THISHREF=http://c.moreover.com/click/here.pl%3fz2443353371%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: World Class Leaders From NCI/OBBR, NIH/OBA, Schering Plough, Merck,deCode Genetics, Biobusiness Consulting, Nahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858577&HITNO=6&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858577&THISHREF=http://c.moreover.com/click/here.pl%3fz2443353281%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858577&HITNO=6&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858577&THISHREF=http://c.moreover.com/click/here.pl%3fz2443353281%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEON: World Class Leaders From NCI/OBBR, NIH/OBA, Schering Plough, Merck,deCode Genetics, Biobusiness Consulting, National Cancer Institute and Other Top Organizations Present Their Recent Experiences at The 2010 Biobanking Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858327&HITNO=7&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858327&THISHREF=http://c.moreover.com/click/here.pl%3fz2443251851%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858327&HITNO=7&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858327&THISHREF=http://c.moreover.com/click/here.pl%3fz2443251851%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: World Class Leaders From NCI/OBBR, NIH/OBA, Schering Plough, Merck,deCode Genetics, Biobusiness Consulting, National Cancer Institute and Other Top Organizations Present Their Recent Experiences at The 2010 Biobanking Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858322&HITNO=8&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858322&THISHREF=http://c.moreover.com/click/here.pl%3fz2443251391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858322&HITNO=8&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858322&THISHREF=http://c.moreover.com/click/here.pl%3fz2443251391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: World Class Leaders From NCI/OBBR, NIH/OBA, Schering Plough, Merck,deCode Genetics, Biobusiness Consulting, National Cancer Insthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858311&HITNO=9&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858311&THISHREF=http://c.moreover.com/click/here.pl%3fz2443249656%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858311&HITNO=9&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858311&THISHREF=http://c.moreover.com/click/here.pl%3fz2443249656%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: World Class Leaders From NCI/OBBR, NIH/OBA, Schering Plough, Merck,deCode Genetics, Biobusinesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858289&HITNO=10&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858289&THISHREF=http://c.moreover.com/click/here.pl%3fz2443241728%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858289&HITNO=10&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858289&THISHREF=http://c.moreover.com/click/here.pl%3fz2443241728%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: World Class Leaders From NCI/OBBR, NIH/OBA, Schering Plough, Merck,deCode Genetics, Biobusiness Consulting, Nahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858219&HITNO=11&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858219&THISHREF=http://c.moreover.com/click/here.pl%3fz2443220176%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858219&HITNO=11&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858219&THISHREF=http://c.moreover.com/click/here.pl%3fz2443220176%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire UK: World Class Leaders From NCI/OBBR, NIH/OBA, Schering Plough, Merck,deCode Genetics, Biobusiness Consulting, Nahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858189&HITNO=12&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858189&THISHREF=http://c.moreover.com/click/here.pl%3fz2443208547%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3858189&HITNO=12&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3858189&THISHREF=http://c.moreover.com/click/here.pl%3fz2443208547%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Merck & Co extends biotech reach with acquisition of UK's Aveciahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3854402&HITNO=13&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3854402&THISHREF=http://c.moreover.com/click/here.pl%3fz2441510208%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3854402&HITNO=13&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3854402&THISHREF=http://c.moreover.com/click/here.pl%3fz2441510208%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Letter: Week of Dec. 21, 2009: Company and People Notes: Merck & Co. Acquires Avecia Biologics; Ambrilia Biopharma Clohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3825601&HITNO=14&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3825601&THISHREF=http://c.moreover.com/click/here.pl%3fz2421657681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3825601&HITNO=14&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Avecia%20Biologics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3825601&THISHREF=http://c.moreover.com/click/here.pl%3fz2421657681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: